Patent intelligence · US
US 2010280048
Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
Patent details — US 2010280048
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 4, 2010
- Expiration
- Oct 30, 2030
- Applicant
- ASTRAZENECA R & D [SE]
- CPC classes
- A61K 31/ 497 A I, A61P 9/ 10 A I, A61P 9/ 12 A I, A61P 11/ 00 A I
Quick answer
US 2010280048 (Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase) is held by ASTRAZENECA R & D [SE]. Status: granted. Granted Nov 4, 2010. Expires Oct 30, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ASTRAZENECA R & D [SE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 497 A I, A61P 9/ 10 A I, A61P 9/ 12 A I, A61P 11/ 00 A I, A61P 11/ 06 A I, A61P 17/ 06 A I
More from ASTRAZENECA R & D [SE]
Related pharmaceutical patents in our USPTO index.
-
IL 240179
Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject
granted -
ZA 201308176
THERAPEUTIC TREATMENT
granted -
SI 2158199
PIPERIDINE COMPOUNDS AND USES THEREOF
granted -
DO P2009000148
DERIVADOS DE ESTER Y AMIDA DE INDAZOLILO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR UN RECEPTOR DE GLUCOCORTICOIDES
granted -
EP 2086964
BENZOYLAMINOHETEROCYCLYLVERBINDUNGEN, DIE SICH FÜR DIE BEHANDLUNG EINER DURCH GLK VERMITTELTEN KRANKHEIT EIGNEN
granted -
EP 2079730
MGLUR5-MODULATOREN
granted -
EP 2064340
VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN
granted
Frequently asked questions
What is US patent 2010280048?
US 2010280048 (Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase) is held by ASTRAZENECA R & D [SE]. Status: granted. Granted Nov 4, 2010. Expires Oct 30, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2010280048?
ASTRAZENECA R & D [SE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2010280048 expire?
Our index shows an expiration date of Oct 30, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.